Hepion Pharmaceuticals In... (HEPA)
0.47
-0.01 (-1.67%)
At close: Apr 03, 2025, 3:57 PM
0.48
1.27%
After-hours: Apr 03, 2025, 05:09 PM EDT
-1.67% (1D)
| Bid | 0.44 |
| Market Cap | 511.92K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -220 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.02 |
| Analyst | n/a |
| Ask | 0.48 |
| Volume | 2,343,452 |
| Avg. Volume (20D) | 2,192,391 |
| Open | 0.46 |
| Previous Close | 0.48 |
| Day's Range | 0.42 - 0.51 |
| 52-Week Range | 0.40 - 145.00 |
| Beta | 1.63 |
About HEPA
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 10, 2014
Employees 22
Stock Exchange NASDAQ
Ticker Symbol HEPA
Website https://www.hepionpharma.com
2 weeks ago
-39.15%
Hepion Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago
-58.05%
Hepion Pharmaceuticals shares are trading lower after the company announced a $9 million public offering.
